Alexon-Trend, its Seradyn division and Remel will be consolidated into one single corporation under the Remel Inc. banner. Provides an extensive line of particle-enhanced immunoassays for therapeutic drug monitoring and serum proteins. Assay areas included turbidimetry, nephelometry, and slide agglutination. This group also provides custom assay development and manufacturing capabilities. Manufactures a variety of monoclonal antibodies to therapeutic drugs, drugs of abuse, cardiac markers, serum proteins and infectious diseases.
Recombinant antigens are also available.
Manufacturers magnetic, polystyrene, carboxylate-modified, dyed and fluorescent microparticles. These microparticles are used as a solid phase for a wide variety of clinical diagnostic assays, research reagents and molecular biology sample preparation applications.